Boenning & Scattergood, Inc. Eli Lilly & CO Transaction History

Boenning & Scattergood, Inc.

$622 Million
Q4 2022

A detailed history of Boenning & Scattergood, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 9,624 shares of LLY stock, worth $8.75 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

9,624

Previous 10,540 8.69%

Holding current value

$8.75 Million

Previous $3.41 Million 19.13%

% of portfolio

0.44%

Previous 0.7%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $294,539 - $343,197	-916 Reduced 8.69%	9,624 $2.76 Million
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $271,575 - $309,488	916 Added 9.52%	10,540 $3.41 Million
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $6,336 - $7,874	27 Added 0.28%	9,624 $2.76 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $50,591 - $62,784	225 Added 2.4%	9,597 $2.65 Million
Q3 2021 Oct 21, 2021	SELL	$221.6 - $272.71 $16,620 - $20,453	-75 Reduced 0.79%	9,372 $2.17 Million
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $22,568 - $29,192	125 Added 1.34%	9,447 $2.17 Million
Q1 2021 Apr 22, 2021	BUY	$164.32 - $212.72 $98,592 - $127,632	600 Added 6.88%	9,322 $1.74 Million
Q4 2020 Jan 20, 2021	BUY	$130.46 - $172.63 $913 - $1,208	7 Added 0.08%	8,722 $1.47 Million
Q3 2020 Oct 21, 2020	BUY	$146.22 - $169.13 $37,139 - $42,959	254 Added 3.0%	8,715 $1.29 Million
Q2 2020 Jul 14, 2020	BUY	$136.42 - $164.18 $423,584 - $509,778	3,105 Added 57.97%	8,461 $1.39 Million
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $1,785 - $2,210	-15 Reduced 0.28%	5,356 $743,000
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $8,009 - $8,712	-75 Reduced 1.38%	5,371 $601,000
Q2 2019 Jul 15, 2019	BUY	$110.79 - $129.32 $47,085 - $54,961	425 Added 8.46%	5,446 $603,000
Q1 2019 Apr 22, 2019	SELL	$111.31 - $131.02 $267,144 - $314,448	-2,400 Reduced 32.34%	5,021 $652,000
Q4 2018 Jan 22, 2019	SELL	$105.9 - $118.64 $300,756 - $336,937	-2,840 Reduced 27.68%	7,421 $859,000
Q3 2018 Oct 05, 2018	BUY	$85.86 - $107.31 $34,344 - $42,924	400 Added 4.06%	10,261 $1.1 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $746,477 - $856,723	9,861 New	9,861 $841,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.

Account

Boenning & Scattergood, Inc. Eli Lilly & CO Transaction History